Knowledge (XXG)

Leflunomide

Source 📝

629: 606: 40: 1217: 1094:, in particular, may lead to severe or even fatal liver-damage or hepatotoxicity. Seventy-five percent of all cases of severe liver damage reported until early 2001 were seen under combined drug therapy leflunomide plus methotrexate. However, some studies have shown that the combination of methotrexate and leflunomide in patients with rheumatoid arthritis gave better results than either drug alone. 31: 1256:"Regardless of the substance administered (leflunomide or teriflunomide), it is the same molecule (teriflunomide)—the one exerting the pharmacological, immunological or metabolic action in view of restoring, correcting or modifying physiological functions, and does not present, in clinical use, a new chemical entity to patients." Because of this, the 4280: 804: 827:
and approved by the U.S. Food and Drug Administration in 1998. Clinical studies regarding the following diseases have been conducted: There has been reports on potential re-purposing of leflunomide for treatment of solid tumors with tumor suppressor, PTEN, loss. In PTEN negative tumors, leflunomide
1142:. Teriflunomide prevents the expansion of activated and autoimmune lymphocytes by interfering with their cell cycle progression while nonlymphoid cells are able to use another pathway to make their ribonucleotides by use of salvage pyrimidine pathway, which makes them less dependent on 942:
The dose-limiting side effects are liver damage, lung disease and immunosuppression. The most common side effects (occurring in >1% of those treated with it) are, in approximately descending order of frequency: diarrhea, respiratory tract infections, hair loss,
2053:
Holtmann MH, Gerts AL, Weinman A, Galle PR, Neurath MF (April 2008). "Treatment of Crohn's disease with leflunomide as second-line immunosuppression : a phase 1 open-label trial on efficacy, tolerability and safety".
2559: 226: 2451: 2298: 1205:
metabolite of leflunomide. Upon administration of leflunomide, 70% of the drug administered converts into teriflunomide. The only difference between the molecules is the opening of the
2010:
Prajapati DN, Knox JF, Emmons J, Saeian K, Csuka ME, Binion DG (August 2003). "Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy".
181: 2366:
Lee SS, Park YW, Park JJ, Kang YM, Nam EJ, Kim SI, et al. (2009). "Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis".
4087: 1352: 4330: 1347:[Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). 1780:
Dai L, Wei XN, Zheng DH, Mo YQ, Pessler F, Zhang BY (June 2011). "Effective treatment of Kimura's disease with leflunomide in combination with glucocorticoids".
239: 62: 2566: 2645: 718: 2412:
Fox RI, Herrmann ML, Frangou CG, Wahl GM, Morris RE, Strand V, et al. (December 1999). "Mechanism of action for leflunomide in rheumatoid arthritis".
1071:
Other immunomodulatory treatments should be avoided due to the potential for additive immunosuppressant effects, or in the case of immunostimulants like
113: 3561: 2462: 2309: 1123:(rUMP), which is required for the synthesis of DNA and RNA. Hence, leflunomide inhibits the reproduction of rapidly dividing cells, especially 4234: 1604: 4097: 4080: 704: 4315: 1340: 3504: 2874: 738: 1311: 955:, urinary tract infection, dizziness, infection, joint disorder, itchiness, weight loss, loss of appetite, cough, gastroenteritis, 2638: 862: 2173:
Pirildar T (May 2003). "Treatment of adult-onset Still's disease with leflunomide and chloroquine combination in two patients".
4073: 3913: 379: 211: 94: 1229:
of leflunomide, responsible for its therapeutic actions. It results from the reaction of isoxazole ring opening, which occurs
1406: 793: 1555: 1087:
vaccines) should be avoided due to the potential for severe infection due to the immunosuppressive nature of the treatment.
887: 1134:, the active metabolite of leflunomide, occurs at levels (approximately 600 nM) that are achieved during treatment of 1348: 1344: 1080: 4270: 1044: 2710: 1112: 847: 797: 505: 130: 4305: 4251: 2819: 2631: 585: 1741:"Current recommendations for diagnosis and management of polyoma BK virus nephropathy in renal transplant recipients" 2531:"Clinical Pharmacology/Biopharmaceutics Review. Product: ARAVA (leflunomide tablets). Application Number: NDA 20905" 2452:"Assessment report. AUBAGIO (international non-proprietary name: teriflunomide). Procedure No. EMEA/H/C/002514/0000" 2221:
for "Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer" at
2689: 1040: 1869:
Sanders S, Harisdangkul V (April 2002). "Leflunomide for the treatment of rheumatoid arthritis and autoimmunity".
1692:"PTEN Regulates Glutamine Flux to Pyrimidine Synthesis and Sensitivity to Dihydroorotate Dehydrogenase Inhibition" 3367: 2530: 1257: 1052: 108: 3747: 454: 1823:
Wu GC, Xu XD, Huang Q, Wu H (February 2013). "Leflunomide: friend or foe for systemic lupus erythematosus?".
1507:"When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?" 1345:"RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" 828:
causes synthetic lethality potentially due to increased demand on pyrimidines in these faster growing cells.
4239: 3742: 991:. Whereas uncommon side effects (occurring in 0.1–1% of those treated with the drug) include: constipation, 167: 624: 4141: 3547: 2973: 2654: 1179: 1151: 867: 316: 1278:"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)" 4136: 3734: 1187: 1120: 445: 1479: 574: 2623: 1277: 1135: 837: 816: 785: 348: 1690:
Mathur D, Stratikopoulos E, Ozturk S, Steinbach N, Pegno S, Schoenfeld S, et al. (April 2017).
39: 4310: 2955: 1048: 948: 852: 842: 820: 789: 601: 400: 174: 4065: 2450:
Melchiorri D, van Zwieten-Boot B, Maciulaitis R, Vilceanu M, Bruins Slot K, Hudson I, et al.
2263:
Teschner S, Burst V (September 2010). "Leflunomide: a drug with a potential beyond rheumatology".
4185: 3904: 3005: 2512: 2391: 2240: 2222: 2198: 2079: 2035: 1943: 1894: 1848: 1805: 1076: 857: 141: 3944: 3802: 872: 3954: 3640: 3081: 4320: 4300: 4128: 3909: 3899: 2700: 2658: 2504: 2429: 2383: 2280: 2190: 2155: 2120: 2071: 2027: 1992: 1935: 1886: 1840: 1797: 1762: 1721: 1669: 1600: 1570: 1536: 1226: 263: 251: 52: 2239:
for "Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid (ARABUL)" at
746:
InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)
554: 3705: 3608: 3271: 3167: 2609: 2496: 2421: 2375: 2334: 2272: 2182: 2147: 2110: 2063: 2019: 1982: 1974: 1925: 1878: 1832: 1789: 1752: 1711: 1703: 1659: 1651: 1526: 1518: 1139: 1000: 992: 641: 298: 1216: 514: 409: 4325: 4284: 4151: 4004: 3889: 1620: 1432: 1175: 1147: 1108: 1020: 892: 494: 326: 306: 823:
are the only indications that have received regulatory approval. Arava was developed by
628: 605: 4245: 3894: 3762: 3410: 3244: 3223: 3219: 3215: 2843: 2680: 1987: 1962: 1716: 1691: 1664: 1639: 1531: 1506: 1146:
synthesis. Teriflunomide also has antiviral effects against numerous viruses including
984: 824: 4294: 4195: 4172: 4118: 4044: 3974: 3884: 3791: 3577: 3277: 3199: 3151: 3131: 2989: 2905: 2756: 2722: 2500: 2395: 2151: 2023: 1882: 1377: 1221: 1198: 1131: 1060: 964: 617: 341: 276: 86: 2516: 2202: 2083: 2039: 1947: 1898: 4219: 4207: 4101: 4054: 4014: 3999: 3994: 3710: 3660: 3655: 3635: 3515: 3510: 3373: 3358: 3306: 3282: 3229: 3106: 3096: 2915: 2832: 2827: 2785: 2738: 2695: 2662: 1852: 1809: 1236: 1159: 1091: 1084: 1032: 1024: 968: 944: 194: 189: 72: 2235: 2217: 1480:"Arava (leflunomide) dosing, indications, interactions, adverse effects, and more" 2614: 2597: 1930: 1913: 1707: 1178:
of 80%, protein binding of >99%, metabolism sites of the GI mucosa and liver,
434: 4181: 4176: 4156: 4049: 3989: 3979: 3969: 3869: 3859: 3849: 3844: 3809: 3720: 3715: 3690: 3680: 3670: 3645: 3630: 3625: 3583: 3553: 3539: 3534: 3520: 3463: 3421: 3416: 3402: 3397: 3383: 3363: 3316: 3292: 3250: 3234: 3205: 3189: 3157: 3141: 3136: 3111: 3061: 3051: 3046: 3041: 3030: 3020: 2925: 2837: 2795: 2780: 2774: 2770: 1124: 1012: 1008: 956: 924: 920: 877: 80: 1505:
Dougados M, Emery P, Lemmel EM, Zerbini CA, Brin S, van Riel P (January 2005).
1260:(EMA) initially had not considered teriflunomide to be a new active substance. 4214: 4202: 4039: 4034: 4019: 3959: 3949: 3934: 3929: 3924: 3874: 3864: 3854: 3819: 3797: 3783: 3695: 3685: 3675: 3665: 3650: 3593: 3588: 3567: 3482: 3477: 3435: 3429: 3330: 3287: 3183: 3173: 3126: 3116: 3091: 3086: 3076: 3071: 3066: 3056: 3015: 3000: 2995: 2979: 2920: 2900: 2849: 2809: 2790: 2732: 2379: 2186: 2138:
Roy M (August 2007). "Early clinical experience with leflunomide in uveitis".
2067: 1836: 1793: 1655: 1036: 1028: 996: 960: 897: 680: 485: 336: 1963:"Six months open label trial of leflunomide in active ankylosing spondylitis" 4146: 4110: 4029: 4024: 4009: 3984: 3939: 3919: 3879: 3814: 3778: 3700: 3496: 3449: 3378: 3344: 3311: 3121: 3101: 3010: 2910: 2750: 1978: 1640:"Leflunomide triggers synthetic lethality in PTEN-deficient prostate cancer" 1522: 1206: 1072: 1056: 1004: 980: 972: 952: 780:
among others, is an immunosuppressive disease-modifying antirheumatic drug (
361: 66: 22: 2508: 2433: 2425: 2387: 2284: 2194: 2159: 2124: 2075: 2031: 1996: 1939: 1890: 1844: 1801: 1766: 1725: 1673: 1574: 1540: 1407:"Arava (leflunomide) tablet, film coated [sanofi-aventis U.S. LLC]" 1213:, the isoxazole ring of leflunomide is opened and teriflunomide is formed. 2115: 2098: 3964: 3839: 3528: 3036: 2946: 2882: 2804: 1757: 1740: 1155: 988: 976: 834: 465: 125: 1158:, which it achieves by inhibiting viral replication by interfering with 474: 30: 3457: 1231: 1016: 967:, vomiting, weakness, allergic reaction, chest pain, dry skin, eczema, 882: 420: 2276: 1638:
Ozturk S, Mathur D, Zhou RW, Mulholland D, Parsons R (December 2020).
1111:
drug that achieves its effects by inhibiting the mitochondrial enzyme
916:
Pregnancy, women of childbearing potential (unless contraception used)
803: 3772: 3603: 2560:"Summary of Opinion (Initial Authorisation): Aubagio (teriflunomide)" 1163: 565: 1190:
of 14–18 days and excretion routes of faeces (48%) and urine (43%).
2308:. Sanofi-Aventis Deutschland GmbH. 21 November 2013. Archived from 534: 3471: 3324: 1215: 802: 781: 703: 694: 545: 3443: 3391: 3352: 3338: 2892: 2766: 1252:-enol being the most stable and therefore most predominant form. 1245: 525: 285: 257: 112: 103: 4069: 2627: 947:, rash, nausea, bronchitis, headache, abdominal pain, abnormal 270: 120: 3300: 1285: 2487:
Rozman B (2002). "Clinical pharmacokinetics of leflunomide".
1079:, reduced therapeutic effects. Likewise live vaccines (like 590: 220: 152: 1599:. Adelaide: The Australian Medicines Handbook Unit Trust. 1007:. Rarely (in 0.1% of those treated with it) it can cause: 2596:
Shankaranarayana S, Barrett C, Kubler P (February 2013).
1961:
Haibel H, Rudwaleit M, Braun J, Sieper J (January 2005).
1378:"Arava 10mg Tablets - Summary of Product Characteristic" 246: 233: 763: 4268: 1914:"New treatment strategies in large-vessel vasculitis" 1685: 1683: 4165: 4127: 4109: 3832: 3760: 3733: 3618: 3261: 2963: 2954: 2945: 2938: 2891: 2873: 2864: 2818: 2749: 2679: 2670: 1248:forms (and the corresponding keto-amide), with the 692: 679: 640: 635: 616: 584: 564: 544: 524: 504: 484: 464: 453: 444: 419: 399: 370: 360: 347: 335: 325: 315: 305: 297: 210: 205: 180: 166: 140: 93: 79: 61: 51: 46: 2344:. sanofi-aventis new zealand limited. 29 June 2012 1235:. Teriflunomide then can interconvert between the 1401: 1399: 1321:. sanofi-aventis australia pty ltd. 7 August 2012 433: 1864: 1862: 408: 2099:"Acute pulmonary exacerbations of sarcoidosis" 1912:Unizony S, Stone JH, Stone JR (January 2013). 1209:ring. Upon oral administration of leflunomide 4081: 2639: 2445: 2443: 8: 1871:The American Journal of the Medical Sciences 1739:Blanckaert K, De Vriese AS (December 2006). 1372: 1370: 129: 21: 2565:. European Medicines Agency. Archived from 4088: 4074: 4066: 2960: 2951: 2942: 2870: 2676: 2646: 2632: 2624: 1138:(RA). Teriflunomide also inhibits several 627: 604: 493: 38: 29: 2613: 2540:. Center for Drug Evaluation and Research 2407: 2405: 2299:"Arava : EPAR - Product Information" 2258: 2256: 2254: 2252: 2250: 2248: 2114: 1986: 1929: 1756: 1715: 1663: 1530: 513: 2097:Panselinas E, Judson MA (October 2012). 1413:. sanofi-aventis U.S. LLC. November 2012 902:Prevention of organ transplant rejection 807:Bottle of Leflunomide (Arava) and tablet 4275: 1269: 1115:(DHODH), which plays a key role in the 743: 723: 600: 473: 384: 85: 2361: 2359: 1644:Prostate Cancer and Prostatic Diseases 1590: 1588: 1586: 1584: 1474: 618: 20: 4331:Disease-modifying antirheumatic drugs 1745:Nephrology, Dialysis, Transplantation 1472: 1470: 1468: 1466: 1464: 1462: 1460: 1458: 1456: 1454: 1306: 1304: 1302: 784:), used in active moderate-to-severe 573: 553: 71: 7: 2368:Scandinavian Journal of Rheumatology 2012:Journal of Clinical Gastroenterology 1627:. U.S. National Library of Medicine. 193: 533: 424: 1556:"Leflunomide in clinical practice" 1355:from the original on 3 August 2023 726:O=C(Nc1ccc(cc1)C(F)(F)F)c2c(onc2)C 14: 2538:U.S. Food and Drug Administration 2140:Canadian Journal of Ophthalmology 1130:The inhibition of human DHODH by 4278: 2501:10.2165/00003088-200241060-00003 2152:10.3129/can.j.ophthalmol.i07-085 2024:10.1097/00004836-200308000-00006 1967:Annals of the Rheumatic Diseases 1883:10.1097/00000441-200204000-00004 1511:Annals of the Rheumatic Diseases 863:Granulomatosis with polyangiitis 664: 658: 652: 57:Arava, Lefumide, Arabloc, others 2056:Digestive Diseases and Sciences 1918:Current Opinion in Rheumatology 1382:electronic Medicines Compendium 751:Key:VHOGYURTWQBHIL-UHFFFAOYSA-N 794:pyrimidine synthesis inhibitor 670: 646: 1: 2461:. p. 119. Archived from 1597:Australian Medicines Handbook 1563:Acta Reumatologica Portuguesa 1081:haemophilus influenzae type b 242:(Other controlled substances) 2711:dihydroorotate dehydrogenase 2615:10.18773/austprescr.2013.010 1931:10.1097/BOR.0b013e32835b133a 1708:10.1158/2159-8290.CD-16-0612 1554:Pinto P, Dougados M (2006). 1113:dihydroorotate dehydrogenase 848:Systemic lupus erythematosus 798:dihydroorotate dehydrogenase 776:, sold under the brand name 2690:purine synthesis inhibitors 2598:"The safety of leflunomide" 1312:"Arava Product Information" 912:Contraindications include: 4347: 1825:Rheumatology International 1384:. Sanofi. 21 February 2014 1351:(published 4 April 2023). 1041:toxic epidermal necrolysis 636:Chemical and physical data 4316:Trifluoromethyl compounds 4229: 2875:IL-1 receptor antagonists 2489:Clinical Pharmacokinetics 2459:European Medicines Agency 2380:10.1080/03009740802360632 2306:European Medicines Agency 2187:10.1007/s10067-002-0667-0 2068:10.1007/s10620-007-9953-7 1837:10.1007/s00296-012-2508-z 1794:10.1007/s10067-011-1689-2 1656:10.1038/s41391-020-0251-1 1437:European Medicines Agency 1258:European Medicines Agency 1053:interstitial lung disease 930:Active serious infections 796:that works by inhibiting 759: 734: 714: 391:--isoxazole-4-carboxamide 375: 366:Faeces (48%), urine (43%) 37: 28: 3748:Anti-lymphocyte globulin 1162:tegumentation and hence 1045:Stevens–Johnson syndrome 3743:Anti-thymocyte globulin 2655:Immunosuppressive drugs 1979:10.1136/ard.2003.019174 1523:10.1136/ard.2003.016709 1349:Diário Oficial da União 1090:The concomitant use of 4142:Sodium aurothiosulfate 3548:Interleukin-6 receptor 2974:Complement component 5 2426:10.1006/clim.1999.4777 2233:Clinical trial number 2215:Clinical trial number 1319:TGA eBusiness Services 1253: 1194:Leflunomide metabolism 1180:volume of distribution 868:Ankylosing spondylitis 808: 4137:Sodium aurothiomalate 2602:Australian Prescriber 2175:Clinical Rheumatology 2116:10.1378/chest.12-1060 1782:Clinical Rheumatology 1595:Rossi S, ed. (2013). 1219: 1188:elimination half-life 1186:) of 0.13 L/kg, 1121:uridine monophosphate 999:, taste disturbance, 806: 1621:"Leflunomide Search" 1136:rheumatoid arthritis 1051:, severe infection, 949:liver function tests 817:Rheumatoid arthritis 786:rheumatoid arthritis 4100:products / DMARDs ( 2414:Clinical Immunology 1201:is the main active 1103:Mechanism of action 1049:lupus erythematosus 989:shortness of breath 945:high blood pressure 821:psoriatic arthritis 790:psoriatic arthritis 331:GI mucosa and liver 266:(Prescription only) 229:(Prescription only) 157: X (High risk) 25: 4306:Immunosuppressants 4256:Never to phase III 4186:Hydroxychloroquine 3905:Diroximel fumarate 3578:IL-2 receptor/CD25 3006:Certolizumab pegol 2659:Immunosuppressants 2335:"Data Sheet Arava" 2241:ClinicalTrials.gov 2223:ClinicalTrials.gov 1758:10.1093/ndt/gfl404 1625:ClinicalTrials.gov 1484:Medscape Reference 1254: 1107:Leflunomide is an 858:Takayasu arteritis 809: 4266: 4265: 4129:Gold preparations 4063: 4062: 3910:Efgartigimod alfa 3900:Dimethyl fumarate 3828: 3827: 3756: 3755: 3729: 3728: 2934: 2933: 2860: 2859: 2701:Mycophenolic acid 2277:10.2217/imt.10.52 1606:978-0-9805790-9-3 1343:(31 March 2023). 1227:active metabolite 908:Contraindications 771: 770: 705:Interactive image 586:CompTox Dashboard 289: 274: 261: 249: 237: 224: 156: 123: 106: 16:Chemical compound 4338: 4283: 4282: 4281: 4274: 4090: 4083: 4076: 4067: 3706:Telimomab aritox 3609:Zolimomab aritox 3430:CD62L/L-selectin 3168:Immunoglobulin E 2961: 2952: 2943: 2871: 2677: 2648: 2641: 2634: 2625: 2619: 2617: 2582: 2581: 2579: 2577: 2572:on 13 March 2016 2571: 2564: 2556: 2550: 2549: 2547: 2545: 2535: 2527: 2521: 2520: 2484: 2478: 2477: 2475: 2473: 2467: 2456: 2447: 2438: 2437: 2409: 2400: 2399: 2363: 2354: 2353: 2351: 2349: 2339: 2331: 2325: 2324: 2322: 2320: 2315:on 11 March 2014 2314: 2303: 2295: 2289: 2288: 2260: 2243: 2231: 2225: 2213: 2207: 2206: 2170: 2164: 2163: 2135: 2129: 2128: 2118: 2094: 2088: 2087: 2050: 2044: 2043: 2007: 2001: 2000: 1990: 1958: 1952: 1951: 1933: 1909: 1903: 1902: 1866: 1857: 1856: 1820: 1814: 1813: 1777: 1771: 1770: 1760: 1736: 1730: 1729: 1719: 1696:Cancer Discovery 1687: 1678: 1677: 1667: 1635: 1629: 1628: 1617: 1611: 1610: 1592: 1579: 1578: 1560: 1551: 1545: 1544: 1534: 1502: 1496: 1495: 1493: 1491: 1476: 1449: 1448: 1446: 1444: 1439:. 25 August 2023 1429: 1423: 1422: 1420: 1418: 1403: 1394: 1393: 1391: 1389: 1374: 1365: 1364: 1362: 1360: 1337: 1331: 1330: 1328: 1326: 1316: 1308: 1297: 1296: 1294: 1292: 1282:nctr-crs.fda.gov 1274: 1170:Pharmacokinetics 1140:tyrosine kinases 1109:immunomodulatory 1001:thrombocytopenia 933:Hypersensitivity 853:Felty's syndrome 843:Kimura's disease 767: 766: 707: 687: 672: 666: 660: 654: 648: 631: 620: 609: 608: 594: 592: 577: 557: 537: 517: 497: 477: 457: 437: 427: 426: 412: 352: 287: 284: 279: 272: 269: 259: 256: 248: 245: 235: 232: 222: 219: 197: 154: 151: 133: 122: 119: 116: 105: 102: 89: 75: 42: 33: 26: 24: 4346: 4345: 4341: 4340: 4339: 4337: 4336: 4335: 4291: 4290: 4289: 4279: 4277: 4269: 4267: 4262: 4261: 4246:Clinical trials 4225: 4161: 4152:Aurothioglucose 4123: 4105: 4094: 4064: 4059: 4005:Rozanolixizumab 3890:Deucravacitinib 3824: 3752: 3725: 3614: 3263: 3257: 2965: 2930: 2887: 2866: 2856: 2814: 2754: 2745: 2681:Antimetabolites 2672: 2666: 2652: 2622: 2595: 2591: 2589:Further reading 2586: 2585: 2575: 2573: 2569: 2562: 2558: 2557: 2553: 2543: 2541: 2533: 2529: 2528: 2524: 2486: 2485: 2481: 2471: 2469: 2468:on 17 July 2015 2465: 2454: 2449: 2448: 2441: 2411: 2410: 2403: 2365: 2364: 2357: 2347: 2345: 2337: 2333: 2332: 2328: 2318: 2316: 2312: 2301: 2297: 2296: 2292: 2262: 2261: 2246: 2232: 2228: 2214: 2210: 2172: 2171: 2167: 2137: 2136: 2132: 2096: 2095: 2091: 2052: 2051: 2047: 2009: 2008: 2004: 1960: 1959: 1955: 1911: 1910: 1906: 1868: 1867: 1860: 1822: 1821: 1817: 1779: 1778: 1774: 1738: 1737: 1733: 1689: 1688: 1681: 1637: 1636: 1632: 1619: 1618: 1614: 1607: 1594: 1593: 1582: 1558: 1553: 1552: 1548: 1504: 1503: 1499: 1489: 1487: 1478: 1477: 1452: 1442: 1440: 1431: 1430: 1426: 1416: 1414: 1405: 1404: 1397: 1387: 1385: 1376: 1375: 1368: 1358: 1356: 1339: 1338: 1334: 1324: 1322: 1314: 1310: 1309: 1300: 1290: 1288: 1276: 1275: 1271: 1266: 1196: 1185: 1176:bioavailability 1174:It has an oral 1172: 1105: 1100: 1069: 1021:agranulocytosis 940: 938:Adverse effects 919:Liver disease, 910: 905: 893:Prostate cancer 888:Still's disease 873:Crohn's disease 814: 762: 760: 755: 752: 747: 742: 741: 730: 727: 722: 721: 710: 685: 675: 669: 663: 657: 651: 612: 588: 580: 560: 540: 520: 500: 480: 460: 440: 423: 415: 395: 392: 383: 382: 350: 317:Protein binding 307:Bioavailability 299:Pharmacokinetic 293: 277: 201: 169: 162: 143: 136: 17: 12: 11: 5: 4344: 4342: 4334: 4333: 4328: 4323: 4318: 4313: 4308: 4303: 4293: 4292: 4288: 4287: 4264: 4263: 4260: 4259: 4258: 4257: 4254: 4243: 4237: 4231: 4230: 4227: 4226: 4224: 4223: 4211: 4199: 4193: 4188: 4179: 4169: 4167: 4163: 4162: 4160: 4159: 4154: 4149: 4144: 4139: 4133: 4131: 4125: 4124: 4122: 4121: 4115: 4113: 4107: 4106: 4095: 4093: 4092: 4085: 4078: 4070: 4061: 4060: 4058: 4057: 4052: 4047: 4042: 4037: 4032: 4027: 4022: 4017: 4012: 4007: 4002: 3997: 3992: 3987: 3982: 3977: 3972: 3967: 3962: 3957: 3952: 3947: 3942: 3937: 3932: 3927: 3922: 3917: 3914:+hyaluronidase 3907: 3902: 3897: 3895:Deuruxolitinib 3892: 3887: 3882: 3877: 3872: 3867: 3862: 3857: 3852: 3847: 3842: 3836: 3834: 3830: 3829: 3826: 3825: 3823: 3822: 3817: 3812: 3807: 3806: 3805: 3800: 3788: 3787: 3786: 3781: 3768: 3766: 3758: 3757: 3754: 3753: 3751: 3750: 3745: 3739: 3737: 3731: 3730: 3727: 3726: 3724: 3723: 3718: 3713: 3708: 3703: 3698: 3693: 3688: 3683: 3678: 3673: 3668: 3663: 3658: 3653: 3648: 3643: 3638: 3633: 3628: 3622: 3620: 3616: 3615: 3613: 3612: 3599: 3598: 3597: 3596: 3591: 3586: 3573: 3572: 3571: 3570: 3558: 3557: 3556: 3544: 3543: 3542: 3537: 3525: 3524: 3523: 3518: 3513: 3501: 3500: 3499: 3488: 3487: 3486: 3485: 3480: 3468: 3467: 3466: 3454: 3453: 3452: 3440: 3439: 3438: 3426: 3425: 3424: 3419: 3407: 3406: 3405: 3400: 3388: 3387: 3386: 3381: 3376: 3371: 3368:+hyaluronidase 3361: 3349: 3348: 3347: 3335: 3334: 3333: 3321: 3320: 3319: 3314: 3309: 3297: 3296: 3295: 3290: 3285: 3280: 3267: 3265: 3259: 3258: 3256: 3255: 3254: 3253: 3240: 3239: 3238: 3237: 3232: 3211: 3210: 3209: 3208: 3195: 3194: 3193: 3192: 3179: 3178: 3177: 3176: 3163: 3162: 3161: 3160: 3147: 3146: 3145: 3144: 3139: 3134: 3129: 3124: 3119: 3114: 3109: 3104: 3099: 3094: 3089: 3084: 3079: 3074: 3069: 3064: 3059: 3054: 3049: 3044: 3039: 3026: 3025: 3024: 3023: 3018: 3013: 3008: 3003: 2998: 2985: 2984: 2983: 2982: 2969: 2967: 2958: 2949: 2940: 2936: 2935: 2932: 2931: 2929: 2928: 2923: 2918: 2913: 2908: 2903: 2897: 2895: 2889: 2888: 2886: 2885: 2879: 2877: 2868: 2862: 2861: 2858: 2857: 2855: 2854: 2853: 2852: 2844:PDE4 inhibitor 2840: 2835: 2830: 2824: 2822: 2816: 2815: 2813: 2812: 2807: 2801: 2800: 2799: 2798: 2793: 2788: 2783: 2762: 2760: 2747: 2746: 2744: 2743: 2742: 2741: 2728: 2727: 2726: 2725: 2720: 2706: 2705: 2704: 2703: 2698: 2685: 2683: 2674: 2668: 2667: 2653: 2651: 2650: 2643: 2636: 2628: 2621: 2620: 2592: 2590: 2587: 2584: 2583: 2551: 2522: 2479: 2439: 2420:(3): 198–208. 2401: 2355: 2326: 2290: 2244: 2226: 2208: 2165: 2130: 2109:(4): 827–836. 2089: 2062:(4): 1025–32. 2045: 2002: 1953: 1904: 1858: 1815: 1772: 1751:(12): 3364–7. 1731: 1702:(4): 380–390. 1679: 1650:(4): 718–723. 1630: 1612: 1605: 1580: 1546: 1497: 1450: 1424: 1395: 1366: 1332: 1298: 1268: 1267: 1265: 1262: 1195: 1192: 1183: 1171: 1168: 1104: 1101: 1099: 1096: 1068: 1065: 985:cholelithiasis 939: 936: 935: 934: 931: 928: 917: 909: 906: 904: 903: 900: 895: 890: 885: 880: 875: 870: 865: 860: 855: 850: 845: 840: 830: 825:Sanofi Aventis 813: 810: 769: 768: 757: 756: 754: 753: 750: 748: 745: 737: 736: 735: 732: 731: 729: 728: 725: 717: 716: 715: 712: 711: 709: 708: 700: 698: 690: 689: 683: 677: 676: 673: 667: 661: 655: 649: 644: 638: 637: 633: 632: 622: 614: 613: 611: 610: 597: 595: 582: 581: 579: 578: 570: 568: 562: 561: 559: 558: 550: 548: 542: 541: 539: 538: 530: 528: 522: 521: 519: 518: 510: 508: 502: 501: 499: 498: 490: 488: 482: 481: 479: 478: 470: 468: 462: 461: 459: 458: 450: 448: 442: 441: 439: 438: 430: 428: 417: 416: 414: 413: 405: 403: 397: 396: 394: 393: 386: 378: 377: 376: 373: 372: 368: 367: 364: 358: 357: 354: 345: 344: 339: 333: 332: 329: 323: 322: 319: 313: 312: 309: 303: 302: 295: 294: 292: 291: 282: 267: 254: 243: 230: 216: 214: 208: 207: 203: 202: 200: 199: 186: 184: 178: 177: 172: 170:administration 164: 163: 161: 160: 158: 148: 146: 138: 137: 135: 134: 117: 99: 97: 91: 90: 83: 77: 76: 69: 59: 58: 55: 49: 48: 44: 43: 35: 34: 15: 13: 10: 9: 6: 4: 3: 2: 4343: 4332: 4329: 4327: 4324: 4322: 4319: 4317: 4314: 4312: 4309: 4307: 4304: 4302: 4299: 4298: 4296: 4286: 4276: 4272: 4255: 4253: 4250: 4249: 4247: 4244: 4241: 4238: 4236: 4233: 4232: 4228: 4221: 4217: 4216: 4212: 4209: 4205: 4204: 4200: 4197: 4196:Sulfasalazine 4194: 4192: 4189: 4187: 4183: 4180: 4178: 4174: 4173:Penicillamine 4171: 4170: 4168: 4164: 4158: 4155: 4153: 4150: 4148: 4145: 4143: 4140: 4138: 4135: 4134: 4132: 4130: 4126: 4120: 4119:Oxycinchophen 4117: 4116: 4114: 4112: 4108: 4103: 4099: 4098:antirheumatic 4091: 4086: 4084: 4079: 4077: 4072: 4071: 4068: 4056: 4053: 4051: 4048: 4046: 4045:Tildrakizumab 4043: 4041: 4038: 4036: 4033: 4031: 4028: 4026: 4023: 4021: 4018: 4016: 4013: 4011: 4008: 4006: 4003: 4001: 3998: 3996: 3993: 3991: 3988: 3986: 3983: 3981: 3978: 3976: 3975:Pegcetacoplan 3973: 3971: 3968: 3966: 3963: 3961: 3958: 3956: 3953: 3951: 3948: 3946: 3943: 3941: 3938: 3936: 3933: 3931: 3928: 3926: 3923: 3921: 3918: 3915: 3911: 3908: 3906: 3903: 3901: 3898: 3896: 3893: 3891: 3888: 3886: 3885:Darvadstrocel 3883: 3881: 3878: 3876: 3873: 3871: 3868: 3866: 3863: 3861: 3858: 3856: 3853: 3851: 3848: 3846: 3843: 3841: 3838: 3837: 3835: 3831: 3821: 3818: 3816: 3813: 3811: 3808: 3804: 3801: 3799: 3796: 3795: 3794: 3793: 3792:TNF inhibitor 3789: 3785: 3782: 3780: 3777: 3776: 3775: 3774: 3770: 3769: 3767: 3764: 3759: 3749: 3746: 3744: 3741: 3740: 3738: 3736: 3732: 3722: 3719: 3717: 3714: 3712: 3709: 3707: 3704: 3702: 3699: 3697: 3694: 3692: 3689: 3687: 3684: 3682: 3679: 3677: 3674: 3672: 3669: 3667: 3664: 3662: 3659: 3657: 3654: 3652: 3649: 3647: 3644: 3642: 3639: 3637: 3634: 3632: 3629: 3627: 3624: 3623: 3621: 3617: 3610: 3606: 3605: 3601: 3600: 3595: 3592: 3590: 3587: 3585: 3582: 3581: 3580: 3579: 3575: 3574: 3569: 3566: 3565: 3564: 3563: 3559: 3555: 3552: 3551: 3550: 3549: 3545: 3541: 3538: 3536: 3533: 3532: 3531: 3530: 3526: 3522: 3519: 3517: 3514: 3512: 3509: 3508: 3507: 3506: 3502: 3498: 3495: 3494: 3493: 3490: 3489: 3484: 3481: 3479: 3476: 3475: 3474: 3473: 3469: 3465: 3462: 3461: 3460: 3459: 3458:CD147/Basigin 3455: 3451: 3448: 3447: 3446: 3445: 3441: 3437: 3434: 3433: 3432: 3431: 3427: 3423: 3420: 3418: 3415: 3414: 3413: 3412: 3408: 3404: 3401: 3399: 3396: 3395: 3394: 3393: 3389: 3385: 3382: 3380: 3377: 3375: 3372: 3369: 3365: 3362: 3360: 3357: 3356: 3355: 3354: 3350: 3346: 3343: 3342: 3341: 3340: 3336: 3332: 3329: 3328: 3327: 3326: 3322: 3318: 3315: 3313: 3310: 3308: 3305: 3304: 3303: 3302: 3298: 3294: 3291: 3289: 3286: 3284: 3281: 3279: 3278:Muromonab-CD3 3276: 3275: 3274: 3273: 3269: 3268: 3266: 3260: 3252: 3249: 3248: 3247: 3246: 3242: 3241: 3236: 3233: 3231: 3228: 3227: 3226: 3225: 3221: 3217: 3213: 3212: 3207: 3204: 3203: 3202: 3201: 3197: 3196: 3191: 3188: 3187: 3186: 3185: 3181: 3180: 3175: 3172: 3171: 3170: 3169: 3165: 3164: 3159: 3156: 3155: 3154: 3153: 3152:Interleukin 5 3149: 3148: 3143: 3140: 3138: 3135: 3133: 3132:Tildrakizumab 3130: 3128: 3125: 3123: 3120: 3118: 3115: 3113: 3110: 3108: 3105: 3103: 3100: 3098: 3095: 3093: 3090: 3088: 3085: 3083: 3080: 3078: 3075: 3073: 3070: 3068: 3065: 3063: 3060: 3058: 3055: 3053: 3050: 3048: 3045: 3043: 3040: 3038: 3035: 3034: 3033: 3032: 3028: 3027: 3022: 3019: 3017: 3014: 3012: 3009: 3007: 3004: 3002: 2999: 2997: 2994: 2993: 2992: 2991: 2987: 2986: 2981: 2978: 2977: 2976: 2975: 2971: 2970: 2968: 2966:(noncellular) 2962: 2959: 2957: 2953: 2950: 2948: 2944: 2941: 2939:Extracellular 2937: 2927: 2924: 2922: 2919: 2917: 2914: 2912: 2909: 2907: 2906:Ridaforolimus 2904: 2902: 2899: 2898: 2896: 2894: 2890: 2884: 2881: 2880: 2878: 2876: 2872: 2869: 2865:Intracellular 2863: 2851: 2848: 2847: 2846: 2845: 2841: 2839: 2836: 2834: 2831: 2829: 2826: 2825: 2823: 2821: 2817: 2811: 2808: 2806: 2803: 2802: 2797: 2794: 2792: 2789: 2787: 2784: 2782: 2779: 2778: 2777: 2776: 2772: 2768: 2764: 2763: 2761: 2758: 2752: 2748: 2740: 2737: 2736: 2735: 2734: 2730: 2729: 2724: 2723:Teriflunomide 2721: 2719: 2716: 2715: 2713: 2712: 2708: 2707: 2702: 2699: 2697: 2694: 2693: 2692: 2691: 2687: 2686: 2684: 2682: 2678: 2675: 2671:Intracellular 2669: 2664: 2660: 2656: 2649: 2644: 2642: 2637: 2635: 2630: 2629: 2626: 2616: 2611: 2607: 2603: 2599: 2594: 2593: 2588: 2568: 2561: 2555: 2552: 2539: 2532: 2526: 2523: 2518: 2514: 2510: 2506: 2502: 2498: 2495:(6): 421–30. 2494: 2490: 2483: 2480: 2464: 2460: 2453: 2446: 2444: 2440: 2435: 2431: 2427: 2423: 2419: 2415: 2408: 2406: 2402: 2397: 2393: 2389: 2385: 2381: 2377: 2373: 2369: 2362: 2360: 2356: 2343: 2336: 2330: 2327: 2311: 2307: 2300: 2294: 2291: 2286: 2282: 2278: 2274: 2271:(5): 637–50. 2270: 2266: 2265:Immunotherapy 2259: 2257: 2255: 2253: 2251: 2249: 2245: 2242: 2238: 2237: 2230: 2227: 2224: 2220: 2219: 2212: 2209: 2204: 2200: 2196: 2192: 2188: 2184: 2180: 2176: 2169: 2166: 2161: 2157: 2153: 2149: 2145: 2141: 2134: 2131: 2126: 2122: 2117: 2112: 2108: 2104: 2100: 2093: 2090: 2085: 2081: 2077: 2073: 2069: 2065: 2061: 2057: 2049: 2046: 2041: 2037: 2033: 2029: 2025: 2021: 2017: 2013: 2006: 2003: 1998: 1994: 1989: 1984: 1980: 1976: 1972: 1968: 1964: 1957: 1954: 1949: 1945: 1941: 1937: 1932: 1927: 1923: 1919: 1915: 1908: 1905: 1900: 1896: 1892: 1888: 1884: 1880: 1876: 1872: 1865: 1863: 1859: 1854: 1850: 1846: 1842: 1838: 1834: 1830: 1826: 1819: 1816: 1811: 1807: 1803: 1799: 1795: 1791: 1788:(6): 859–65. 1787: 1783: 1776: 1773: 1768: 1764: 1759: 1754: 1750: 1746: 1742: 1735: 1732: 1727: 1723: 1718: 1713: 1709: 1705: 1701: 1697: 1693: 1686: 1684: 1680: 1675: 1671: 1666: 1661: 1657: 1653: 1649: 1645: 1641: 1634: 1631: 1626: 1622: 1616: 1613: 1608: 1602: 1598: 1591: 1589: 1587: 1585: 1581: 1576: 1572: 1569:(3): 215–24. 1568: 1564: 1557: 1550: 1547: 1542: 1538: 1533: 1528: 1524: 1520: 1516: 1512: 1508: 1501: 1498: 1485: 1481: 1475: 1473: 1471: 1469: 1467: 1465: 1463: 1461: 1459: 1457: 1455: 1451: 1438: 1434: 1428: 1425: 1412: 1408: 1402: 1400: 1396: 1383: 1379: 1373: 1371: 1367: 1354: 1350: 1346: 1342: 1336: 1333: 1320: 1313: 1307: 1305: 1303: 1299: 1287: 1283: 1279: 1273: 1270: 1263: 1261: 1259: 1251: 1247: 1244: 1243: 1239: 1234: 1233: 1228: 1224: 1223: 1222:Teriflunomide 1218: 1214: 1212: 1208: 1204: 1200: 1199:Teriflunomide 1193: 1191: 1189: 1181: 1177: 1169: 1167: 1165: 1161: 1157: 1153: 1149: 1145: 1141: 1137: 1133: 1132:teriflunomide 1128: 1126: 1122: 1119:synthesis of 1118: 1114: 1110: 1102: 1097: 1095: 1093: 1088: 1086: 1082: 1078: 1074: 1066: 1064: 1062: 1061:liver failure 1058: 1054: 1050: 1046: 1042: 1038: 1034: 1030: 1026: 1022: 1018: 1014: 1010: 1006: 1002: 998: 994: 990: 986: 982: 978: 974: 970: 966: 965:tenosynovitis 962: 958: 954: 951:, back pain, 950: 946: 937: 932: 929: 926: 922: 918: 915: 914: 913: 907: 901: 899: 896: 894: 891: 889: 886: 884: 881: 879: 876: 874: 871: 869: 866: 864: 861: 859: 856: 854: 851: 849: 846: 844: 841: 839: 836: 832: 831: 829: 826: 822: 818: 811: 805: 801: 799: 795: 791: 787: 783: 779: 775: 765: 758: 749: 744: 740: 733: 724: 720: 713: 706: 702: 701: 699: 696: 691: 684: 682: 678: 645: 643: 639: 634: 630: 626: 623: 621: 619:ECHA InfoCard 615: 607: 603: 602:DTXSID9023201 599: 598: 596: 587: 583: 576: 572: 571: 569: 567: 563: 556: 552: 551: 549: 547: 543: 536: 532: 531: 529: 527: 523: 516: 512: 511: 509: 507: 503: 496: 492: 491: 489: 487: 483: 476: 472: 471: 469: 467: 463: 456: 452: 451: 449: 447: 443: 436: 432: 431: 429: 422: 418: 411: 407: 406: 404: 402: 398: 390: 385: 381: 374: 369: 365: 363: 359: 355: 353: 346: 343: 342:Teriflunomide 340: 338: 334: 330: 328: 324: 320: 318: 314: 310: 308: 304: 300: 296: 290: Rx-only 283: 280: 268: 265: 255: 253: 244: 241: 231: 228: 218: 217: 215: 213: 209: 204: 196: 191: 188: 187: 185: 183: 179: 176: 173: 171: 165: 159: 150: 149: 147: 145: 139: 132: 127: 118: 115: 110: 101: 100: 98: 96: 92: 88: 84: 82: 78: 74: 70: 68: 64: 60: 56: 54: 50: 47:Clinical data 45: 41: 36: 32: 27: 19: 4220:Azathioprine 4213: 4208:Methotrexate 4201: 4190: 4055:Upadacitinib 4015:Satralizumab 4000:Ritlecitinib 3995:Risankizumab 3790: 3771: 3711:Teprotumumab 3661:Inebilizumab 3656:Fontolizumab 3636:Atorolimumab 3604:T-lymphocyte 3602: 3576: 3560: 3546: 3527: 3516:Lerdelimumab 3511:Bertilimumab 3503: 3491: 3470: 3456: 3442: 3428: 3409: 3390: 3374:Pascolizumab 3359:Obinutuzumab 3351: 3337: 3323: 3307:Clenoliximab 3299: 3283:Otelixizumab 3270: 3243: 3230:Lebrikizumab 3214: 3198: 3182: 3166: 3150: 3107:Satralizumab 3097:Risankizumab 3029: 2988: 2972: 2964:Serum target 2916:Temsirolimus 2842: 2833:Pomalidomide 2828:Lenalidomide 2786:Pimecrolimus 2765: 2739:Methotrexate 2731: 2717: 2709: 2696:Azathioprine 2688: 2673:(initiation) 2608:(1): 28–32. 2605: 2601: 2574:. Retrieved 2567:the original 2554: 2542:. Retrieved 2537: 2525: 2492: 2488: 2482: 2470:. Retrieved 2463:the original 2458: 2417: 2413: 2371: 2367: 2346:. Retrieved 2341: 2329: 2317:. Retrieved 2310:the original 2305: 2293: 2268: 2264: 2234: 2229: 2216: 2211: 2178: 2174: 2168: 2143: 2139: 2133: 2106: 2102: 2092: 2059: 2055: 2048: 2018:(2): 125–8. 2015: 2011: 2005: 1973:(1): 124–6. 1970: 1966: 1956: 1921: 1917: 1907: 1877:(4): 190–3. 1874: 1870: 1831:(2): 273–6. 1828: 1824: 1818: 1785: 1781: 1775: 1748: 1744: 1734: 1699: 1695: 1647: 1643: 1633: 1624: 1615: 1596: 1566: 1562: 1549: 1517:(1): 44–51. 1514: 1510: 1500: 1488:. Retrieved 1483: 1441:. Retrieved 1436: 1433:"Arava EPAR" 1427: 1415:. Retrieved 1410: 1386:. Retrieved 1381: 1357:. Retrieved 1335: 1323:. Retrieved 1318: 1289:. Retrieved 1281: 1272: 1255: 1249: 1241: 1237: 1230: 1220: 1210: 1202: 1197: 1173: 1160:nucleocapsid 1143: 1129: 1116: 1106: 1098:Pharmacology 1092:methotrexate 1089: 1085:yellow fever 1083:vaccine and 1070: 1067:Interactions 1047:, cutaneous 1033:pancytopenia 1025:eosinophilia 969:paraesthesia 941: 927:seropositive 911: 815: 777: 773: 772: 761:   388: 349:Elimination 212:Legal status 206:Legal status 95:License data 18: 4242:from market 4191:Leflunomide 4182:Chloroquine 4177:Bucillamine 4157:Aurotioprol 4050:Tofacitinib 3990:Ravulizumab 3980:Pirfenidone 3970:Peficitinib 3870:Canakinumab 3860:Briakinumab 3850:Bimekizumab 3845:Baricitinib 3810:Aflibercept 3721:Vepalimomab 3716:Vapaliximab 3691:Rovelizumab 3681:Pexelizumab 3671:Morolimumab 3646:Cedelizumab 3631:Anifrolumab 3626:Alemtuzumab 3584:Basiliximab 3554:Tocilizumab 3540:Vedolizumab 3535:Natalizumab 3521:Metelimumab 3464:Gavilimomab 3422:Toralizumab 3417:Teneliximab 3403:Lumiliximab 3398:Gomiliximab 3384:Ublituximab 3364:Ocrelizumab 3317:Zanolimumab 3293:Visilizumab 3251:Secukinumab 3235:Ustekinumab 3206:Elsilimomab 3190:Faralimomab 3158:Mepolizumab 3142:Ustekinumab 3137:Tocilizumab 3112:Secukinumab 3062:Canakinumab 3052:Briakinumab 3047:Bimekizumab 3042:Basiliximab 3031:Interleukin 3021:Nerelimomab 2926:Zotarolimus 2867:(reception) 2838:Thalidomide 2796:Voclosporin 2781:Ciclosporin 2775:Calcineurin 2771:Cyclophilin 2718:Leflunomide 2714:inhibitors 2374:(1): 11–4. 2236:NCT00802243 2218:NCT00004071 1125:lymphocytes 1013:angiooedema 1009:anaphylaxis 993:oral thrush 957:pharyngitis 953:indigestion 921:hepatitis B 878:Sarcoidosis 838:nephropathy 812:Medical use 774:Leflunomide 688: g·mol 625:100.123.883 371:Identifiers 337:Metabolites 131:Leflunomide 81:MedlinePlus 53:Trade names 23:Leflunomide 4311:Isoxazoles 4295:Categories 4215:thiopurine 4203:antifolate 4111:Quinolines 4040:Sutimlimab 4035:Spesolimab 4020:Siltuximab 3960:Olokizumab 3950:Ixekizumab 3945:Itacitinib 3935:Guselkumab 3930:Fingolimod 3925:Filgotinib 3875:Crovalimab 3865:Brodalumab 3855:Blisibimod 3820:Rilonacept 3803:Opinercept 3798:Etanercept 3784:Belatacept 3735:Polyclonal 3696:Siplizumab 3686:Reslizumab 3676:Ofatumumab 3666:Maslimomab 3651:Emapalumab 3594:Inolimomab 3589:Daclizumab 3568:Odulimomab 3483:Ruplizumab 3478:Frexalimab 3436:Aselizumab 3331:Efalizumab 3288:Teplizumab 3184:Interferon 3174:Omalizumab 3127:Spesolimab 3117:Siltuximab 3092:Rilonacept 3087:Olokizumab 3077:Ixekizumab 3072:Guselkumab 3067:Daclizumab 3057:Brodalumab 3016:Infliximab 3001:Afelimomab 2996:Adalimumab 2980:Eculizumab 2956:Monoclonal 2947:Antibodies 2921:Umirolimus 2901:Everolimus 2850:Apremilast 2810:Gusperimus 2791:Tacrolimus 2759:inhibitors 2751:Macrolides 2733:antifolate 2181:(2): 157. 2146:(4): 634. 1924:(1): 3–9. 1291:22 October 1264:References 1166:assembly. 1077:astragalus 1037:vasculitis 1029:leucopenia 997:stomatitis 961:stomatitis 898:Pemphigoid 792:. It is a 693:3D model ( 681:Molar mass 555:CHEBI:6402 515:G162GK9U4W 486:ChemSpider 446:IUPHAR/BPS 410:75706-12-6 401:CAS Number 380:IUPAC name 356:14–18 days 327:Metabolism 4252:Phase III 4240:Withdrawn 4147:Auranofin 4096:Specific 4030:Sirukumab 4025:Siponimod 4010:Sarilumab 3985:Ponesimod 3955:Netakimab 3940:Iptacopan 3920:Etrasimod 3880:Danicopan 3815:Alefacept 3779:Abatacept 3701:Talizumab 3641:Begelomab 3497:Belimumab 3450:Galiximab 3379:Rituximab 3345:Erlizumab 3312:Keliximab 3122:Sirukumab 3102:Sarilumab 3082:Netakimab 3011:Golimumab 2911:Sirolimus 2396:205543918 1443:26 August 1359:16 August 1207:isoxazole 1073:echinacea 1057:cirrhosis 981:synovitis 973:pneumonia 575:ChEMBL960 387:5-methyl- 362:Excretion 351:half-life 168:Routes of 142:Pregnancy 73:Monograph 67:Drugs.com 4321:Prodrugs 4301:Anilides 4285:Medicine 3965:Ozanimod 3840:Avacopan 3833:Unsorted 3619:Unsorted 3529:Integrin 3262:Cellular 3037:Anakinra 2883:Anakinra 2805:Abetimus 2657: / 2576:15 April 2544:15 April 2517:33745823 2509:12074690 2434:10600330 2388:19191187 2348:11 March 2319:11 March 2285:20874647 2203:41656726 2195:12740686 2160:17641721 2125:23032450 2084:29918308 2076:17934840 2040:21212960 2032:12869881 1997:15608310 1948:21101525 1940:23114585 1899:28479334 1891:12003373 1845:22961090 1802:21286771 1767:16998219 1726:28255082 1674:32661432 1575:17094333 1541:15271770 1490:11 March 1417:11 March 1411:DailyMed 1388:11 March 1353:Archived 1325:11 March 1156:BK virus 1154:and the 977:rhinitis 835:BK virus 833:Polyoma 764:(verify) 466:DrugBank 240:Class C1 182:ATC code 175:By mouth 144:category 126:DailyMed 3761:-cept ( 2342:Medsafe 1988:1755172 1853:7202069 1810:1914281 1717:5562025 1665:7666085 1532:1755199 1486:. WebMD 1232:in vivo 1225:is the 1211:in vivo 1203:in vivo 1144:de novo 1117:de novo 1017:anaemia 883:Uveitis 686:270.211 642:Formula 475:DB01097 421:PubChem 321:>99% 281:Rx-only 278:WARNING 250:: 198:) 192: ( 190:L04AK01 128::  111::  87:a600032 4326:Sanofi 4271:Portal 4235:WHO-EM 3773:CTLA-4 3763:Fusion 3264:target 3245:IL-17A 3222:, and 2755:other 2515:  2507:  2472:5 June 2432:  2394:  2386:  2283:  2201:  2193:  2158:  2123:  2082:  2074:  2038:  2030:  1995:  1985:  1946:  1938:  1897:  1889:  1851:  1843:  1808:  1800:  1765:  1724:  1714:  1672:  1662:  1603:  1573:  1539:  1529:  1341:Anvisa 1246:enolic 1164:virion 719:SMILES 566:ChEMBL 535:D00749 275: 262: 252:℞-only 238: 225: 124:  114:by INN 107:  4166:Other 3562:LFA-1 3472:CD154 3325:CD11a 3224:IL-23 3220:IL-13 3216:IL-12 2820:IMiDs 2570:(PDF) 2563:(PDF) 2534:(PDF) 2513:S2CID 2466:(PDF) 2455:(PDF) 2392:S2CID 2338:(PDF) 2313:(PDF) 2302:(PDF) 2199:S2CID 2103:Chest 2080:S2CID 2036:S2CID 1944:S2CID 1895:S2CID 1849:S2CID 1806:S2CID 1559:(PDF) 1315:(PDF) 1005:hives 782:DMARD 778:Arava 739:InChI 695:JSmol 546:ChEBI 4102:M01C 3492:BLyS 3444:CD80 3411:CD40 3392:CD23 3353:CD20 3339:CD18 3200:IL-6 2893:mTOR 2767:FKBP 2757:IL-2 2578:2016 2546:2016 2505:PMID 2474:2015 2430:PMID 2384:PMID 2350:2014 2321:2014 2281:PMID 2191:PMID 2156:PMID 2121:PMID 2072:PMID 2028:PMID 1993:PMID 1936:PMID 1887:PMID 1841:PMID 1798:PMID 1763:PMID 1722:PMID 1670:PMID 1601:ISBN 1571:PMID 1537:PMID 1492:2014 1445:2023 1419:2014 1390:2014 1361:2023 1327:2014 1293:2023 1240:and 1152:HSV1 1059:and 1003:and 987:and 819:and 788:and 526:KEGG 506:UNII 495:3762 455:6825 435:3899 301:data 63:AHFS 4222:) # 3505:CAT 3301:CD4 3272:CD3 2990:TNF 2663:L04 2610:doi 2497:doi 2422:doi 2376:doi 2273:doi 2183:doi 2148:doi 2111:doi 2107:142 2064:doi 2020:doi 1983:PMC 1975:doi 1926:doi 1879:doi 1875:323 1833:doi 1790:doi 1753:doi 1712:PMC 1704:doi 1660:PMC 1652:doi 1527:PMC 1519:doi 1286:FDA 1148:CMV 1075:or 591:EPA 425:CID 311:80% 264:POM 195:WHO 109:EMA 4297:: 4248:: 4210:#) 4184:#/ 4175:#/ 3218:, 2606:36 2604:. 2600:. 2536:. 2511:. 2503:. 2493:41 2491:. 2457:. 2442:^ 2428:. 2418:93 2416:. 2404:^ 2390:. 2382:. 2372:38 2370:. 2358:^ 2340:. 2304:. 2279:. 2267:. 2247:^ 2197:. 2189:. 2179:22 2177:. 2154:. 2144:42 2142:. 2119:. 2105:. 2101:. 2078:. 2070:. 2060:53 2058:. 2034:. 2026:. 2016:37 2014:. 1991:. 1981:. 1971:64 1969:. 1965:. 1942:. 1934:. 1922:25 1920:. 1916:. 1893:. 1885:. 1873:. 1861:^ 1847:. 1839:. 1829:33 1827:. 1804:. 1796:. 1786:30 1784:. 1761:. 1749:21 1747:. 1743:. 1720:. 1710:. 1698:. 1694:. 1682:^ 1668:. 1658:. 1648:23 1646:. 1642:. 1623:. 1583:^ 1567:31 1565:. 1561:. 1535:. 1525:. 1515:64 1513:. 1509:. 1482:. 1453:^ 1435:. 1409:. 1398:^ 1380:. 1369:^ 1317:. 1301:^ 1284:. 1280:. 1182:(V 1150:, 1127:. 1063:. 1055:, 1043:, 1039:, 1035:, 1031:, 1027:, 1023:, 1019:, 1015:, 1011:, 995:, 983:, 979:, 975:, 971:, 963:, 959:, 800:. 650:12 286:EU 271:US 258:UK 247:CA 234:BR 227:S4 221:AU 153:AU 121:US 104:EU 4273:: 4218:( 4206:( 4198:# 4104:) 4089:e 4082:t 4075:v 3916:) 3912:( 3765:) 3611:) 3607:( 3370:) 3366:( 2773:/ 2769:/ 2753:/ 2665:) 2661:( 2647:e 2640:t 2633:v 2618:. 2612:: 2580:. 2548:. 2519:. 2499:: 2476:. 2436:. 2424:: 2398:. 2378:: 2352:. 2323:. 2287:. 2275:: 2269:2 2205:. 2185:: 2162:. 2150:: 2127:. 2113:: 2086:. 2066:: 2042:. 2022:: 1999:. 1977:: 1950:. 1928:: 1901:. 1881:: 1855:. 1835:: 1812:. 1792:: 1769:. 1755:: 1728:. 1706:: 1700:7 1676:. 1654:: 1609:. 1577:. 1543:. 1521:: 1494:. 1447:. 1421:. 1392:. 1363:. 1329:. 1295:. 1250:Z 1242:Z 1238:E 1184:d 925:C 923:/ 697:) 674:2 671:O 668:2 665:N 662:3 659:F 656:9 653:H 647:C 593:) 589:( 389:N 288:: 273:: 260:: 236:: 223:: 155:: 65:/

Index



Trade names
AHFS
Drugs.com
Monograph
MedlinePlus
a600032
License data
EMA
by INN
DailyMed
Leflunomide
Pregnancy
category

Routes of
administration

By mouth
ATC code
L04AK01
WHO
Legal status
S4
Class C1
℞-only
POM
WARNING
Pharmacokinetic
Bioavailability
Protein binding
Metabolism
Metabolites

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.